Skip to main content

Gritstone bio, Inc.

GRTSDelisted Mar 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001656634

Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Gritstone bio, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of GRTS: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders79156−22
Shares39.2M872.0K35.6M−2.71M (−7.1%)
Value$24.2M$538.8K$20.7M−$3.04M (−12.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Gritstone bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to GRTS in Q3 2024
InstitutionSharesValue% of portfolio
Siren, L.L.C.3,318,093$1.92M0.10%
BlackRock, Inc.870,271$504.7K0.00%
Two Sigma Investments, LP133,261$77.3K0.00%
Kingsview Wealth Management, LLC35,000$20.3K0.00%
Virtu Financial LLC23,172$13.0K0.00%
Qube Research & Technologies Ltd21,600$12.5K0.00%
GWM Advisors LLC500$2900.00%
Northwestern Mutual Wealth Management Co100$580.00%
TD Waterhouse Canada Inc.11$20.00%

Sold out (31)

Institutions that held Gritstone bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Gritstone bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GRTS in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.871,995$538.8K